Medtronic has been making significant strides in its Cranial & Spinal Technologies (CST) business unit recently.
GALWAY, Ireland - Medtronic (NYSE:MDT) announced today it has received U.S. Food and Drug Administration clearance for its Stealth AXiS surgical system, an integrated platform combining planning, ...
The Stealth AXiSTM system is cleared for spine procedures in the United States, with an underlying architecture designed to support future cranial and ENT applications, pending 510(k) clearance. Built ...
The U.S. Food and Drug Administration classified a software glitch with Medtronic's StealthStation S8 surgical navigation system as a Class I recall, the most serious issued by the agency.
GALWAY, Ireland, Feb. 13, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS ...